跳至主要内容
临床试验/EUCTR2019-002037-11-NO
EUCTR2019-002037-11-NO进行中(未招募)1 期

Intravenous Iron supplement for Iron deficiency in patients with Severe Aortic Stenosis - IIISAS

Oslo University Hospital0 个研究点目标入组 100 人开始时间: 2019年8月6日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients with aortic stenosis with peak flow velocity (>3.5 m/s) scheduled for aortic valve replacement with transcatheter aortic valve implantation
  • Iron deficiency defined as serum ferritin < 100 µg/l or ferritin between 100 and 300 µg/l in combination with a transferrin saturation < 20 %.
  • Age > 18 years.
  • Signed informed consent and expected compliance with protocol.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 70

排除标准

  • Contraindications to study medication.
  • Failure to obtain written informed consent
  • Inability to walk at least 100 meters over 6 minutes

研究者

发起方
Oslo University Hospital

相似试验